16.18 percent based on the net tangible asset basis, being considered as a Class 2 transaction under the Notification on Acquisition or Disposal of Assets. As a result, the Company is required to
shareholders of the Bank and Permata granting approval for the Transaction and the approvals of the Bank of Thailand (“BOT”) and of Otoritas Jasa Keuangan (“OJK”) of Indonesia being granted for all matters
financial statements and operation result of Nam San 3A for fiscal year of 2016, 2017 and 20183 (using the average exchange rate being at LAK 291.46 to THB 1 as of 17 January 2020 announced by the Bank of
, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 9. Expected Benefits for the Company: The company expects to benefit from the opportunity of being more competitive
applying Net Operating Profit after tax deduction criteria and is considered a class 2 transaction under the Announcement of the Acquisition or Disposal, being 15 percent or higher but lower than 50 percent
the par value of the Company after being granted approval from the shareholders’ meeting pursuant to Section 52 of the Public Limited Companies Act B.E. 2535 (as amended). PP Transactions are considered
Crossroads not Page 4 of 5 being consolidated upon the Company’s investment in 1st Phase Development of Crossroads in February 2018, as mentioned previously. Other Business Performance of this part constitutes
sale/purchase ( ) Other (please specify) 3. Date of filing this report to the SEC 02/10/2019 90-day period (the first day being the date of action under item 2 which give rise to this reporting
Biglot Mr.KYUNG JUN YU ( ) Direct sale/purchase ( ) Other (please specify) 3. Date of filing this report to the SEC 12/12/2019 90-day period (the first day being the date of action under item 2
via Zcom Securities 3. Date of filing this report to the SEC 12/12/2019 90-day period (the first day being the date of action under item 2 which give rise to this reporting obligation) 1.04 Baht/Unit